• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Quicktouch Technologies Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
77759
INE0K4D01020
145.2450485
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
QUICKTOUCH
0
31.34
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Bajaj Healthcare secures SEC recommendation for Cenobamate tablets
Jun 27,2026
Bajaj Healthcare specializes in manufacturing intermediates, API, formulations & Nutraceuticals. The Company has state-of-art manufacturing facilities of APIs, intermediates and formulations. These facilities are designed to meet the requirements of both advanced as well as emerging market opportunities. BHL has a strong presence globally in countries like Europe, USA, Australia, Middle East and South America.

The company reported a standalone net loss of Rs 22.85 crore in Q4 FY26, compared with a net profit of Rs 11.17 crore posted in Q4 FY25. Revenue from operations shed 0.91% YoY to Rs 153.05 crore in Q4 FY26, compared with Rs 154.47 crore in the corresponding quarter last year.

The counter declined 1.91% to settle at Rs 305.50 on the BSE.